The immunomodulatory effect of ketamine in colorectal cancer surgery: a randomized-controlled trial.

CONCLUSIONS: Intraoperative low-dose ketamine administration did not convey any favourable impacts on overall postoperative NK cell activity, inflammatory responses, and prognosis in colorectal cancer surgery patients.
TRIAL REGISTRATION: www.clinicaltrial.gov (NCT03273231); registered 6 September 2017.
PMID: 33532995 [PubMed - as supplied by publisher]

Source: Canadian Journal of Anaesthesia - February 2, 2021 Category: Anesthesiology Authors: Cho JS, Kim NY, Shim JK, Jun JH, Lee S, Kwak YL Tags: Can J Anaesth Source Type: research